SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-21-048057
Filing Date
2021-04-08
Accepted
2021-04-08 16:11:16
Documents
2
Group Members
JEREMY C. GREENREDMILE BIOPHARMA INVESTMENTS II, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tm2112372d1_sc13g.htm SC 13G 110344
2 EXHIBIT 99.1 tm2112372d1_ex99-1.htm EX-99.1 5585
  Complete submission text file 0001104659-21-048057.txt   117599
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address YALELAAN 60 UTRECHT P7 3584 CM
Business Address YALELAAN 60 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Subject) CIK: 0001840748 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92425 | Film No.: 21815044
SIC: 2834 Pharmaceutical Preparations